To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
77 Newest Publications about the topic non-hodgkin's lymphoma
rss
Post‐Marketing Observational Study on 5% Intravenous Immunoglobulin Therapy (Alphaglobin®/Flebogamma®) in Secondary Immunodeficiency with Recurrent Serious Bacterial Infections
22-04-2013 | Georg Günther, Bettina Dreger, Microbiology and Immunology, 2013
Abstract Secondary hypogammaglobulinemia is one of the factors responsible for the increased susceptibility to infection in chronic lymphocytic leukemia (CLL). This study reports the experience with Flebogamma® (formely Alphaglobin®) 5% intravenous immunoglobulin (IVIG) solution in ...
Alterations in serum immunoglobulin levels in workers occupationally exposed to trichloroethylene
01-04-2013 | Luoping Zhang; Bryan A. Bassig; Joseph L. Mora; Roel Vermeulen; Yichen Ge; John D. Curry; Wei Hu; Min Shen; Chuangyi ..., Carcinogenesis , 2013
Trichloroethylene (TCE) has been associated with a variety of immunotoxic effects and may be associated with an increased risk of non-Hodgkin lymphoma (NHL). Altered serum immunoglobulin (Ig) levels have been reported in NHL patients and in animals exposed to TCE. Recently, we reported that ...
An Integrated Computational/Experimental Model of Lymphoma Growth
28-03-2013 | Hermann B. Frieboes et al., PLoS Computational Biology, 2013
by Hermann B. Frieboes, Bryan R. Smith, Yao-Li Chuang, Ken Ito, Allison M. Roettgers, Sanjiv S. Gambhir, Vittorio Cristini Non-Hodgkin's lymphoma is a disseminated, highly malignant cancer, with resistance to drug treatment based on molecular- and tissue-scale characteristics that ...
At diagnosis, diffuse large B‐cell lymphoma patients show impaired rituximab–mediated NK‐cell cytotoxicity
11-02-2013 | Anne Danielou‐Lazareth, Guylaine Henry, Daniela Geromin, Zena Khaznadar, Josette Briere, Ryad Tamouza, Jean‐Michel C ..., European Journal of Immunology, 2013
Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin's lymphoma in adults. It is generally treated by a combination of chemotherapy and CD20‐specific monoclonal antibodies, such as rituximab, which act, at least partially, by activating antibody‐dependent ...
Low expression of dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein in non-Hodgkin lymphoma and significant correlations with lactic acid dehydrogenase and β2-microglobulin
06-02-2013 | Zhuqing Zhang, Kai Chen, Longchao Yan, Ziyi Yang, Zhanmeng Zhu, Chunlin Chen, Jia Zeng, Wei Wei, Xia Qi, Shuangyi Re ..., Biochemistry and Cell Biology, 2013
On rapporte que DC-SIGNR, une protéine membranaire intégrale de type II membre des lectines de type C, se lie à différentes souches de VIH-1, VIH-2 et de virus d’immunodéficience simienne. La DC-SIGNR sérique n’est pas actuellement utilisée pour détecter les lymphomes non-hodgkiniens (LNH). ...
Viruses, Vol. 5, Pages 439-469: HCV and Oxidative Stress in the Liver
28-01-2013 | Ivanov, Alexander V.; Bartosch, Birke ; Smirnova, Olga A.; Isaguliants, Maria G.; Kochetkov, Sergey N., Viruses, 2013
Hepatitis C virus (HCV) is the etiological agent accounting for chronic liver disease in approximately 2–3% of the population worldwide. HCV infection often leads to liver fibrosis and cirrhosis, various metabolic alterations including steatosis, insulin and interferon resistance or ...
High‐resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to non‐hodgkin's lymphoma
23-01-2013 | Carlos Aya‐Bonilla, Michael R. Green, Emily Camilleri, Miles Benton, Colm Keane, Paula Marlton, Rod Lea, Maher K. Ga ..., Genes, Chromosomes and Cancer, 2013
Abstract We employed a Hidden‐Markov‐Model (HMM) algorithm in loss of heterozygosity (LOH) analysis of high‐density single nucleotide polymorphism (SNP) array data from Non‐Hodgkin's lymphoma (NHL) entities, follicular lymphoma (FL), and diffuse large B‐cell lymphoma (DLBCL). This ...
Tissue flow cytometry immunophenotyping in the diagnosis and classification of non‐Hodgkin's lymphomas: A retrospective evaluation of 1,792 cases
16-01-2013 | Anna Demurtas, Alessandra Stacchini, Sabrina Aliberti, Luigi Chiusa, Roberto Chiarle, Domenico Novero, Cytometry Part B: Clinical Cytometry, 2013
Abstract A retrospective analysis of 1,792 solid tissues suggestive of lymphoma, submitted over a 12‐year period, was carried out and flow cytometry (FC) results were compared with histologic findings. The final histologic diagnosis of cases documented in this report is as follows: 1,270 ...
Aberration in DNA Methylation in B-Cell Lymphomas Has a Complex Origin and Increases with Disease Severity
10-01-2013 | Subhajyoti De et al., PLoS Genetics, 2013
by Subhajyoti De, Rita Shaknovich, Markus Riester, Olivier Elemento, Huimin Geng, Matthias Kormaksson, Yanwen Jiang, Bruce Woolcock, Nathalie Johnson, Jose M. Polo, Leandro Cerchietti, Randy D. Gascoyne, Ari Melnick, Franziska Michor Despite mounting evidence that epigenetic ...
Phytanic acid and the risk of non-Hodgkin lymphoma
01-01-2013 | Nicholas J. Ollberding; Briseis Aschebrook-Kilfoy; Donne Bennett D. Caces; Margaret E. Wright; Dennis D. Weisenburg ..., Carcinogenesis , 2013
Greater consumption of red meat, processed meat and dairy products has been associated with an increased risk of non-Hodgkin lymphoma (NHL) in several previous reports. Phytanic acid, a saturated fatty acid obtained primarily through the consumption of ruminant meat and dairy products, may ...
Netmeeting
